These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14708894)

  • 21. DNA fragmentation and cell proliferation correlated with tumor grade in patients with hepatocellular carcinoma.
    Kalogeraki A; Garbagnati F; Santinami M; Zoras O
    Cancer; 2002 Oct; 96(5):301-5. PubMed ID: 12378598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Kwon SH; Jeong SW; Jang JY; Lee JE; Lee SH; Kim SG; Kim YS; Cho YD; Kim HS; Kim BS; Jin SY
    Clin Mol Hepatol; 2012 Sep; 18(3):287-94. PubMed ID: 23091809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C.
    Nanba S; Ikeda F; Baba N; Takaguchi K; Senoh T; Nagano T; Seki H; Takeuchi Y; Moritou Y; Yasunaka T; Ohnishi H; Miyake Y; Takaki A; Nouso K; Iwasaki Y; Yamamoto K
    J Clin Pathol; 2016 Mar; 69(3):226-33. PubMed ID: 26290259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large liver cell change in hepatitis B virus-related liver cirrhosis.
    Kim H; Oh BK; Roncalli M; Park C; Yoon SM; Yoo JE; Park YN
    Hepatology; 2009 Sep; 50(3):752-62. PubMed ID: 19585549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C.
    Horiike S; Kawanishi S; Kaito M; Ma N; Tanaka H; Fujita N; Iwasa M; Kobayashi Y; Hiraku Y; Oikawa S; Murata M; Wang J; Semba R; Watanabe S; Adachi Y
    J Hepatol; 2005 Sep; 43(3):403-10. PubMed ID: 16023246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver.
    Mun KS; Cheah PL; Baharudin NB; Looi LM
    Malays J Pathol; 2006 Dec; 28(2):73-7. PubMed ID: 18376794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of the 8-oxodG/dG ratio in chronic liver inflammation of patients with hepatocellular carcinoma.
    Li P; Ramm GA; Macdonald GA
    Redox Biol; 2016 Aug; 8():259-70. PubMed ID: 26890046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease.
    Kitada T; Seki S; Iwai S; Yamada T; Sakaguchi H; Wakasa K
    J Hepatol; 2001 Nov; 35(5):613-8. PubMed ID: 11690707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions.
    Reis H; Bertram S; Pott L; Canbay A; Gallinat A; Baba HA
    Pathol Oncol Res; 2017 Jan; 23(1):33-39. PubMed ID: 27276915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.
    Zhou JW; Li Y; Yue LX; Luo CL; Chen Y; Zhang JY
    Tumour Biol; 2016 Feb; 37(2):2547-53. PubMed ID: 26386724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis.
    Wang D; Zhang X; Lu Y; Wang X; Zhu L
    Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical localization of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissues.
    Kitagawa Y; Iwai M; Muramatsu A; Tanaka S; Mori T; Harada Y; Okanoue T; Kashima K
    Histopathology; 2002 May; 40(5):472-9. PubMed ID: 12010368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis and Fas system are significantly involved in the process of liver cirrhosis converting into hepatocellular carcinoma.
    Peng Z; Tang H; Ling Y; Han G
    J Tongji Med Univ; 2001; 21(2):126-9, 148. PubMed ID: 11523216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.
    Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN
    J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased hepatic oxidative DNA damage in patients with hepatocellular carcinoma.
    Schwarz KB; Kew M; Klein A; Abrams RA; Sitzmann J; Jones L; Sharma S; Britton RS; Di Bisceglie AM; Groopman J
    Dig Dis Sci; 2001 Oct; 46(10):2173-8. PubMed ID: 11680593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.
    Li W; Liao X; Ning P; Cao Y; Zhang M; Bu Y; Lv J; Jia Q
    BMC Cancer; 2019 Apr; 19(1):395. PubMed ID: 31029128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
    Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma.
    Palaiologou M; Koskinas J; Karanikolas M; Fatourou E; Tiniakos DG
    Virchows Arch; 2012 May; 460(5):439-46. PubMed ID: 22450712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA synthesis activities of hepatocytes from noncancerous cirrhotic tissue and of hepatocellular carcinoma (HCC) cells from cancerous tissue can predict the survival of hepatectomized patients with HCC.
    Tarao K; Ohkawa S; Shimizu A; Harada M; Nakamura Y; Okamoto N; Ito Y; Tamai S; Iimori K; Sugimasa Y
    Cancer; 1993 Jun; 71(12):3859-63. PubMed ID: 8389652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.